Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Ironwood Pharmaceuticals (IRWD) Shares Issued (2016 - 2025)

Ironwood Pharmaceuticals' Shares Issued history spans 15 years, with the latest figure at $122000.0 for Q4 2025.

On a quarterly basis, Shares Issued fell 39.9% to $122000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $216000.0, a 98.04% decrease, with the full-year FY2025 number at $216000.0, down 98.04% from a year prior.
Shares Issued hit $122000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from $88000.0 in the prior quarter.
Over the last five years, Shares Issued for IRWD hit a ceiling of $10.1 million in Q1 2024 and a floor of $6000.0 in Q1 2025.
Historically, Shares Issued has averaged $2.6 million across 5 years, with a median of $1.5 million in 2022.
Biggest five-year swings in Shares Issued: soared 820.0% in 2021 and later crashed 99.94% in 2025.
Tracing IRWD's Shares Issued over 5 years: stood at $5.5 million in 2021, then plummeted by 49.39% to $2.8 million in 2022, then crashed by 64.43% to $998000.0 in 2023, then crashed by 79.66% to $203000.0 in 2024, then crashed by 39.9% to $122000.0 in 2025.
Business Quant data shows Shares Issued for IRWD at $122000.0 in Q4 2025, $88000.0 in Q2 2025, and $6000.0 in Q1 2025.